GPR146 as a therapeutic target: Linking lipid metabolism with macrophage inflammation in atherosclerosis.
Atherosclerosis is driven by dyslipidemia and chronic inflammation. GPR146 has emerged as a regulator of cholesterol metabolism; however, whether GPR146 links lipid metabolism with macrophage inflammation during atherosclerosis remains unclear. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat diet for 12 w...